Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Signos Inc
With
Lindus Health, Inc.
The scope of this study is to enroll participants into a study that utilizes a continuous glucose monitor (CGM) and mobile health application \[Signos\] to optimize general wellness and body weight and composition. The Signos users will be compared against a control arm.
Age
22–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
To join our study, participant need to:
Be at least 22 years old.
Be overweight or obese, which we define as having a Body Mass Index (BMI) between 25 and 40.
HbA1c test result should be below 6.5% at the start of the study.
Have and know how to use a smartphone that's compatible with the Signos app.
Be able to understand, speak, and read English well enough to participate fully in the study.
You may not be if
Participant can't join our study if participant has:
Have Type 1 or Type 2 diabetes.
Are already using a device to monitor glucose level.
Have severe allergies to the sticky part of glucose monitors.
Suffer from an eating disorder like anorexia or bulimia.
Are currently taking certain medications for diabetes or weight loss.
Have had or are planning to have weight loss surgery.
Have major health issues like severe kidney disease, untreated thyroid problems, or skin conditions where the glucose monitor would be placed.
Have been part of another clinical trial recently.
Clareo Health | Using Signos mHealth Platform in Adults for Weight Management
